immuno oncology frontiers world miami


Amy Hines

Amy Hines

Director for Collection Network Management, Be The Match Biotherapies

Amy Hines is the Senior Manager of Apheresis and Collection Center Network Development for Be The Match BioTherapies. She oversees the performance of Apheresis Centers and Cell Therapy Labs in the Network, and ensures their ongoing compliance with FDA and International standards and criteria, industry best practices, and appropriate regulatory and accrediting entities.

She joined Be The Match BioTherapies’ parent company, the National Marrow Donor Program® (NMDP)/Be The Match®, in 2013 managing the NMDP/Be The Match Apheresis and Collection Center Network of more than 90 Apheresis Centers and 80 Collection Centers.

Amy has nearly 20 years of experience in the cellular therapy field, starting her career as a stem cell transplant registered nurse. She received her Bachelor of Science in Nursing from Grand Valley State University in Allendale, Mich.

  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy